|
|
|
The papers included in this volume were part of the technical conference cited on the cover and title page. Papers were selected and subject to review by the editors and conference program committee. Some conference presentations may not be available for publication. The papers published in these proceedings reflect the work and thoughts of the authors and are published herein as submitted. The publisher is not responsible for the validity of the information or for any outcomes resulting from reliance thereon. Please use the following format to cite material from this book: Author(s), “Title of Paper,” in Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIV, edited by David H. Kessel, Tayyaba Hasan, Proceedings of SPIE Vol. 9308 (SPIE, Bellingham, WA, 2015) Article CID Number. ISSN: 1605-7422 ISBN: 9781628413984 Published by SPIE P.O. Box 10, Bellingham, Washington 98227-0010 USA Telephone +1 360 676 3290 (Pacific Time) · Fax +1 360 647 1445 Copyright © 2015, Society of Photo-Optical Instrumentation Engineers. Copying of material in this book for internal or personal use, or for the internal or personal use of specific clients, beyond the fair use provisions granted by the U.S. Copyright Law is authorized by SPIE subject to payment of copying fees. The Transactional Reporting Service base fee for this volume is $18.00 per article (or portion thereof), which should be paid directly to the Copyright Clearance Center (CCC), 222 Rosewood Drive, Danvers, MA 01923. Payment may also be made electronically through CCC Online at copyright.com. Other copying for republication, resale, advertising or promotion, or any form of systematic or multiple reproduction of any material in this book is prohibited except with permission in writing from the publisher. The CCC fee code is 1605-7422/15/$18.00. Printed in the United States of America. Publication of record for individual papers is online in the SPIE Digital Library.
Paper Numbering: Proceedings of SPIE follow an e-First publication model, with papers published first online and then in print. Papers are published as they are submitted and meet publication criteria. A unique citation identifier (CID) number is assigned to each article at the time of the first publication. Utilization of CIDs allows articles to be fully citable as soon as they are published online, and connects the same identifier to all online, print, and electronic versions of the publication. SPIE uses a six-digit CID article numbering system in which:
The CID Number appears on each page of the manuscript. The complete citation is used on the first page, and an abbreviated version on subsequent pages. AuthorsNumbers in the index correspond to the last two digits of the six-digit citation identifier (CID) article numbering system used in Proceedings of SPIE. The first four digits reflect the volume number. Base 36 numbering is employed for the last two digits and indicates the order of articles within the volume. Numbers start with 00, 01, 02, 03, 04, 05, 06, 07, 08, 09, 0A, 0B...0Z, followed by 10-1Z, 20-2Z, etc. Abdel-Kader, Mahmoud, 13 Anand, Sanjay, 0H, 0Q Awazu, Kunio, 14 Baran, Timothy M., 0J Betz, Vaughn, 0O Bölük-basi Ates, Gamze, 0X Breymayer, J., 0R Burgucu, Mehmet Necmi, 0X Cassidy, Jeffrey, 0O Cengel, Keith A., 09 Chen, Bin, 0K Chen, Kuizhi, 0L, 0U Chen, Zhenzhen, 0U Choi, Mi-Ran, 0T Clare, Susan, 0T Darafsheh, Arash, 12 Dimofte, Andreea, 09 Elliott, Jonathan T., 11 Fang, Qianqian, 0T Finlay, Jarod C., 09, 0V, 12 Foster, Thomas H., 0J Friedberg, Joseph S., 09, 12 Gomaa, Iman, 13 Hasan, Tayyaba, 11 Hazama, Hisanao, 14 Honda, Norihiro, 14 Huang, Zheng, 0L, 0U Inai, Mizuho, 14 Isik, Sevim, 0X Jacques, Steven L., 09 Kaneda, Yasufumi, 14 Kessel, David, 02 Kim, Michele M., 09, 0A, 0N, 0V Kiris, Tugba, 0X Kraus, Daniel, 0K Lilge, Lothar, 0O Liu, Jiangsheng, 0U Loschenov, V., 0R Maytin, Edward V., 0H, 0Q Murray, Christopher B., 12 Najmr, Stan, 12 Nakamura, Hiroyuki, 14 Nishida, Tomoki, 14 Paik, Taejong, 12 Pan, Sujuan, 0U Peng, Yiru, 0L, 0U Penjweini, Rozhin, 09, 0A, 0N Pogue, Brian W., 11 Prabhu Verleker, Akshay, 0T Rollakanti, Kishore, 0H, 0Q Rück, A., 0R Ryabova, A., 0R Sagir, Tugba, 0X Samkoe, Kimberley S., 11 Saraya, Hend, 13 Senel, Mehmet, 0X Simone, Charles B., II, 09 Sinha, Lagnojita, 11 Stantz, Keith M., 0T Steiner, R., 0R Tabakoglu, Hasim Ozgur, 0X Tachikawa, Shoji, 14 Tenuto, Michael E., 12 Tichauer, Kenneth M., 11 Wang, Xiongwei, 0L Wen, Junri, 0U Wong, Rosemary S. L., 0E Yamauchi, Masaya, 14 Yasuda, Hidehiro, 14 Zekri, Maha, 13 Zhu, Timothy C., 09, 0A, 0N, 0V Conference CommitteeSymposium Chairs
Program Track Chair Conference Chairs
Conference Program Committee
Session Chairs
IntroductionSPIE has been sponsoring conferences related to photodynamic therapy since 1987. These were initially organized by Thomas Dougherty, but more recently (since 2003) by David H. Kessel, with Tayyaba Hasan added in 2011. We attempt to bring together a cross-section of major workers in the field along with new investigators that periodically appear. Contributions include both basic science and clinical applications. PDT research was initially directed at finding out what malignant conditions could be treated and attempts at drug development. The early products tended to be somewhat non-specific and could result in persistent skin photosensitization. More recent photosensitizers have improved specificity, sometimes as a result of targeting via nanotechnology or immunologic processes. Light sources and dosimetry determination have also improved. Several effects have served to limit the impact of PDT on health care. Some pharmaceutical organizations in the United States have not seen sufficient profits in the PDT field. Funding for basic and clinical research has remained flat, resulting in decreased support. It appears that more active programs are occurring in Europe and Asia, for a variety of reasons. In spite of such difficulties, some of which have affected PDT since early days, the field does continue to progress. Examples of successful therapy for neoplastic disease and other indications continue to be demonstrated. The efficacy of this form of therapy in some cases remains superior to all other options. David H. Kessel Tayyaba Hasan |
